ストックスクリーナーアプリを入手
0.93
3.91%
0.035
アフターアワーズ：
.95
0.02
+2.15%
Cytosorbents Corp (CTSO) 最新ニュース
Granahan Investment Management Reduces Stake in CytoSorbents Cor - GuruFocus.com
FY2024 EPS Estimates for Cytosorbents Decreased by Analyst - Defense World
FY2024 EPS Estimate for Cytosorbents Decreased by Analyst - MarketBeat
Cytosorbents Corporation (NASDAQ:CTSO) Q3 2024 Earnings Call Transcript - Insider Monkey
CytoSorbents And Converge Biotech Announce Strategic - GlobeNewswire
CytoSorbents Expands Into India Through Strategic Converge Biotech Partnership | CTSO Stock News - StockTitan
StockNews.com Initiates Coverage on Cytosorbents (NASDAQ:CTSO) - MarketBeat
CytoSorbents Corp (CTSO) Q3 2024 Earnings Call Highlights: Stron - GuruFocus.com
CytoSorbents Corp (CTSO) Q3 2024 Earnings Call Highlights: Strong Sales Growth and Improved ... - Yahoo Finance
Cytosorbents Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
CytoSorbents Corporation’s Q3 2024 Financial Highlights - TipRanks
CytoSorbents: Q3 Earnings Snapshot - CT Insider
CytoSorbents Reports Third Quarter 2024 Financial and Operational Results - StockTitan
CytoSorbents Corp (CTSO) Q3 2024: Everything You Need to Know Ah - GuruFocus.com
CytoSorbents Corp (CTSO) Q3 2024: Everything You Need to Know Ahead of Earnings - Yahoo Finance
CytoSorbents (STU:HQE1) 3-Year EPS without NRI Growth Rate : -38.10% (As of Jun. 2024) - GuruFocus.com
CytoSorbents (STU:HQE1) 3-Year EBITDA Growth Rate : -37.70% (As of Jun. 2024) - GuruFocus.com
CytoSorbents (STU:HQE1) 3-Year FCF Growth Rate : -39.10% (As of Jun. 2024) - GuruFocus.com
CytoSorbents (STU:HQE1) 5-Day RSI : 14.64 (As of Nov. 05, 2024) - GuruFocus.com
CytoSorbents (STU:HQE1) Operating Income : €-23.16 Mil (TTM As of Jun. 2024) - GuruFocus.com
CytoSorbents Submits Health Canada Medical Device License Application for DrugSorb-ATR Following MDSAP Certification - StockTitan
Cytosorbents (NASDAQ:CTSO) Coverage Initiated by Analysts at StockNews.com - MarketBeat
Cytosorbents (CTSO) to Release Earnings on Thursday - MarketBeat
Cytosorbents (NASDAQ:CTSO) and Caliber Imaging & Diagnostics (OTCMKTS:LCDX) Critical Comparison - Defense World
Analyst Scoreboard: 5 Ratings For CytoSorbents - Benzinga
Expert Outlook: CytoSorbents Through The Eyes Of 5 Analysts - Benzinga
FDA begins review of CytoSorbents' bleeding reduction device - Investing.com
FDA begins review of CytoSorbents' bleeding reduction device By Investing.com - Investing.com UK
FDA Accepts DrugSorb-ATR De Novo Application To Reduce the Severity of CABG-Related Bleeding Due to Ticagrelor and Initiates Substantive Review - StockTitan
CytoSorbents (STU:HQE1) Forward Dividend Yield % : 0.00% (As of Nov. 05, 2024) - GuruFocus.com
CytoSorbents to Report Third Quarter 2024 Operating and Financial Results - StockTitan
Cytosorbents (NASDAQ:CTSO) Now Covered by Analysts at StockNews.com - MarketBeat
Cytosorbents Co. (NASDAQ:CTSO) Short Interest Down 5.7% in September - MarketBeat
CytoSorbents Corp (CTSO) Q2 2024 Earnings Call Highlights: Revenue Growth and Strategic ... - Yahoo Finance
CytoSorbents maintains Buy rating from B.Riley with no change in target price - Investing.com
Cytosorbents announces $20 million "at the market" equity offering - Investing.com
Cytosorbents Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Other Events, Financial Statements and Exhibits - Quantisnow
DrugSorb-ATR seeks FDA priority review for surgery bleeding - Investing.com
CytoSorbents Submits DrugSorb-ATR Marketing Application to U.S. FDA to Reduce the Severity of Bleeding in Heart Bypass Surgery Patients on the Blood Thinner Ticagrelor and Provides Business Update - The Manila Times
Cytosorbents (NASDAQ:CTSO) Research Coverage Started at StockNews.com - MarketBeat
Cytosorbents (NASDAQ:CTSO) shareholders have endured a 81% loss from investing in the stock three years ago - Yahoo Finance
Cytosorbents (NASDAQ:CTSO) Earns Hold Rating from Analysts at StockNews.com - MarketBeat
Cytosorbents (NASDAQ:CTSO) Now Covered by StockNews.com - MarketBeat
Stocks of Cytosorbents Corp (CTSO) are poised to climb above their peers - SETE News
Technical analysis of Cytosorbents Corp (CTSO) stock chart patterns - US Post News
Cytosorbents (NASDAQ:CTSO) Share Price Passes Above Two Hundred Day Moving Average of $0.94 - MarketBeat
CytoSorbents to Present at the H.C. Wainwright 26ᵗʰ Annual Global Investment Conference - Yahoo Finance
Cytosorbents (NASDAQ:CTSO) Receives New Coverage from Analysts at StockNews.com - Defense World
1.38%
0.43%
大文字化:
|
ボリューム (24 時間):